Arbutus Biopharma Director Dumps Nearly 18,000 Shares Amid Widespread Insider Sell‑off, Market Reacts with Sharp Price Dip and Buzz Spike
Arbutus Biopharma insider selling signals a strategic shift: CEO, CFO, and top execs sell shares, raising questions about the stock’s future and the impact on investor sentiment.
3 minutes to read